• Ibrexafungerp: Translational Insights from In Vitro to In Vi

  2026-05-09

  Explore the translational potential of Ibrexafungerp (MK 3118) with a deep dive into its unique mechanism, preclinical efficacy, and advanced applications in antifungal research. This article offers an original perspective on assay selection and practical deployment, supported by authoritative evidence.

• Adefovir (GS-0393): Applied Workflows in HBV Antiviral Resea

  2026-05-08

  Adefovir (GS-0393) enables precise inhibition of hepatitis B virus replication through selective DNA polymerase targeting and OAT1-mediated pharmacokinetic profiling. This article translates reference-driven innovations into actionable protocols for HBV research, transporter studies, and troubleshooting, with a focus on experimental rigor and reproducibility.

• BMN 673 (Talazoparib): Next-Gen PARP Inhibition for DNA Repa

  2026-05-08

  This thought-leadership article provides translational researchers with mechanistic clarity and strategic foresight for leveraging BMN 673 (Talazoparib) in homologous recombination deficient cancer models. Drawing on recent mechanistic advances—particularly the BRCA2–RAD51–PARP1 interplay—this piece integrates evidence-based guidance, competitive insights, and actionable protocol parameters for experimental and preclinical pipelines. The article is distinct in contextualizing the latest findings on PARP-DNA trapping and PI3K pathway modulation, offering a roadmap for innovation in precision oncology.

• (-)-Arctigenin: Mechanistic Insights as a MEK1 Inhibitor in

  2026-05-07

  Explore the mechanistic role of (-)-Arctigenin as a MEK1 inhibitor in tumor immunology. This in-depth analysis uncovers unique assay guidance and translational insights for research on the tumor microenvironment and macrophage-driven signaling.

• Safe DNA Gel Stain: Sensitive, Safer DNA and RNA Visualizati

  2026-05-07

  Safe DNA Gel Stain is a high-sensitivity DNA and RNA gel stain that reduces mutagenic risk and enables blue-light or UV visualization. Compared to ethidium bromide, it offers safer handling and improved cloning efficiency. This article details its mechanism, validated benchmarks, and practical workflow guidance.

• ARCA Cy5 EGFP mRNA (5-moUTP): Defining Standards for Quantit

  2026-05-06

  Explore how ARCA Cy5 EGFP mRNA (5-moUTP) advances quantitative mRNA localization and translation efficiency assays in mammalian cells. Discover unique scientific insights on immune-evasive, fluorescently labeled mRNA for delivery analysis, and learn how cutting-edge reference research shapes best practices.

• FAST Platform: Food-Grade Nanoparticles for Enhanced Nutrace

  2026-05-06

  The referenced study introduces the Facilitated Self-Assembling Technology (FAST) platform, a surfactant-free, food-grade method for creating biocompatible nutraceutical nanoparticles. This innovation overcomes major challenges in solubility, stability, and regulatory compliance, offering a scalable path toward next-generation oral nutraceutical delivery systems.

• CB-5083 and p97: Bridging Protein Homeostasis and DNA Repair

  2026-05-05

  Explore how CB-5083, a potent p97 inhibitor, advances cancer and aging research by connecting proteostasis disruption with novel DNA repair mechanisms. This article offers a unique, translational perspective on CB-5083's utility, grounded in recent molecular insights.

• Applied Use-Cases of Recombinant Human EGF in Cell Assays

  2026-05-05

  Leverage recombinant human EGF to drive reproducible cell proliferation and advanced 3D-tumor spheroid assays, setting a new standard for stemness evaluation and mucosal protection studies. Discover protocol refinements and troubleshooting strategies that maximize performance and reliability with APExBIO’s high-purity EGF.

• Pharmacokinetic Variability of CSBTA in MASH: PXR and CYP3A

  2026-05-04

  This study systematically evaluated the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in mouse models of metabolic dysfunction-associated steatohepatitis (MASH). The findings reveal that pathological liver status and PXR-mediated regulation of cytochrome P450 enzymes significantly alter drug disposition, highlighting the need for tailored therapeutic strategies in MASLD/MASH.

• QPRT Drives Breast Cancer Invasion via PLC-Dependent Pathway

  2026-05-04

  Liu et al. reveal that quinolinate phosphoribosyltransferase (QPRT) enhances breast cancer invasiveness through signaling pathways leading to myosin light chain phosphorylation. The study demonstrates that inhibiting the phospholipase C (PLC) pathway—using U-73122 among other inhibitors—suppresses QPRT-driven cell migration, providing mechanistic insights and new experimental routes for targeting metastatic behavior.

• EZ Cap Cy5 Firefly Luciferase mRNA: Workflow & Imaging Edge

  2026-05-03

  EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP) empowers researchers with dual-mode, immune-evasive mRNA for high-fidelity delivery tracking and robust translation in mammalian cells. This article details workflow upgrades, troubleshooting, and strategic insights for maximizing translational assays and advanced imaging applications.

• H-89: Precision cAMP-Dependent Protein Kinase Inhibitor in S

  2026-05-02

  H-89 provides researchers a potent and selective approach to dissecting cAMP/PKA-mediated signaling pathways, enabling reliable metabolic and osteogenic assays. This guide delivers actionable protocol enhancements, advanced use-cases, and troubleshooting strategies, directly informed by latest findings in bone biology and metabolic rewiring.

• CAY10499: Precision Lipase Inhibition for Lipid Signaling Re

  2026-05-01

  Explore how CAY10499, a potent inhibitor of human hormone sensitive lipase, enables precise dissection of lipid signaling in metabolic and immunological research. This article uniquely examines the compound’s mechanistic selectivity and its implications for advanced assay design.

• WNT5a/GSK3/β-catenin Axis Regulates FAP Adipogenesis in Musc

  2026-05-01

  This study identifies the WNT5a/GSK3/β-catenin signaling axis as a critical regulator of adipogenic differentiation in skeletal muscle fibro/adipogenic progenitors (FAPs). The findings offer mechanistic insight into muscle regeneration and fat infiltration, with implications for targeting the Wnt pathway in muscle disease models.

15863 records 1/1058 page Next 12345 下5页 Last page